Related Experiment Videos
B-cell activating properties of polymyxin B.
Scandinavian Journal of Immunology
|January 1, 1978
Summary
Polymyxin B can enhance specific immune responses, acting as an adjuvant for primary immune responses. This study investigated its effects on lipopolysaccharide-activated B cells, revealing its potential to modulate immune activity.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Polymyxins are recognized inhibitors of polyclonal B cell activators like lipopolysaccharide (LPS) and dextran sulfate.
- Previous research indicated polymyxins could enhance specific immune responses when combined with certain mitogens.
Purpose of the Study:
- To investigate the impact of polymyxin B on superoptimal polyclonal doses of lipopolysaccharide (LPS).
- To determine if polymyxin B exhibits adjuvant properties in a primary immune response model.
Main Methods:
- Administered polymyxin B in conjunction with superoptimal doses of lipopolysaccharide (LPS).
- Assessed immune responses to sheep erythrocytes in the presence of polymyxin B.
Main Results:
- Polymyxin B demonstrated effects similar to those observed with hapten-LPS conjugates, modulating B cell activation.
- Polymyxin B exhibited significant adjuvant properties, enhancing the primary immune response to sheep erythrocytes.
- Polymyxin B was identified as a thymus-independent antigen.
Conclusions:
- Polymyxin B can modulate polyclonal B cell activation induced by lipopolysaccharide.
- Polymyxin B possesses adjuvant capabilities, enhancing T-cell independent immune responses.
- These findings highlight polymyxin B's complex role in modulating immune system activity.